VERA

Vera Therapeutics, Inc. Class A Common Stock

VERA
Closed
$42.09
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

The company is headquartered in Brisbane California, California and currently employs 249 full-time employees. The company went IPO on 2021-05-14.
Country

US

CEO

Dr. Marshall Fordyce

IPO date

2021

Employees

249

ISIN

US92337R1014

Website

veratx.com

Key stats

Open

$42.21

Volume

2.75M

Market cap

$2.42B

Prev. close

$42.45

Impl / hst vl

-

Open interest

$0.00

$41.00

Day’s Range

$43.15

$30.59

52W Range

$50.84

Valuation

44
Valuation score
Fairly Valued
P/E
-
P/S
-
P/B
6.07
Current ratio
13.64
Debt / Equity
-0.08
ROE
-74.86%
Gross margin
-
Income growth
32.86%
FCF growth
52.18

Analysts estimates

Consensus rating
Buy

The average rating from top 11 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$78.93
The top 16 analysts forecasts that 12-month price may increase by 87.53%, with a low of $35.35 and a high of $115.50
$35.35
Low
$78.93
Avg
$115.50
High
Current price

Earnings

Q1 ‘26 revenue
$0.00
Q1 ‘26 net income
-$121.03M
Revenue
Net income
Previous EPS
-$1.69
Estimate EPS
-$1.65
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply